Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Takata

Showing results (11-20 of 74) with videos related to

Pageof 8
Sort By:
Experimental Animals|January 1, 1995
Initial arthritic lesions induced by immunization with type II collagen in Lewis ratsM Takeshita, H Hinoue, O Furukawa, et al.
Cellular Immunology|October 1, 1985
Demonstration of a macrophage migration enhancement factor in the sera of young rabbitsI Takata, M R Gordon, Q N Myrvik
Japanese Journal of Pharmacology|June 1, 1997
The novel anti-rheumatic drug TA-383 has a macrophage migration enhancing activityM Ueno, T Sugita, T Murakami, et al.
Jikken Dobutsu. Experimental Animals|January 1, 1994
Histopathological study of arthritic lesions induced by immunization with type II collagen in Lewis ratsM Takeshita, H Hinoue, O Furukawa, et al.
QJM : Monthly Journal of the Association of Physicians|November 11, 2023
Hunter's glossitis and autoimmune gastritis: a case reportN Oda, H Takakura, M Maeda, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patientsN Takigawa, Y Segawa, Y Maeda, et al.
Endocrinologia Japonica|October 1, 1979
A case of the syndrome of inappropriate secretion of TSHT Sato, K Saida, Y Suzuki, et al.
Acta Medica Okayama|August 1, 1992
Establishment and characterization of a cell line, KaMi, from human lung large cell carcinomaH Takata, T Yoshino, Y Hoshida, et al.
International Journal of Immunopharmacology|July 1, 1995
Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritisM Ueno, K Imaizumi, T Sugita, et al.
Internal Medicine (Tokyo, Japan)|October 1, 1996
Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancerY Maeda, Y Segawa, N Takigawa, et al.
Pageof 8

Showing results (11-20 of 74) with videos related to

Sort By:
Pageof 8
Experimental Animals|January 1, 1995
Initial arthritic lesions induced by immunization with type II collagen in Lewis ratsM Takeshita, H Hinoue, O Furukawa, et al.
Cellular Immunology|October 1, 1985
Demonstration of a macrophage migration enhancement factor in the sera of young rabbitsI Takata, M R Gordon, Q N Myrvik
Japanese Journal of Pharmacology|June 1, 1997
The novel anti-rheumatic drug TA-383 has a macrophage migration enhancing activityM Ueno, T Sugita, T Murakami, et al.
Jikken Dobutsu. Experimental Animals|January 1, 1994
Histopathological study of arthritic lesions induced by immunization with type II collagen in Lewis ratsM Takeshita, H Hinoue, O Furukawa, et al.
QJM : Monthly Journal of the Association of Physicians|November 11, 2023
Hunter's glossitis and autoimmune gastritis: a case reportN Oda, H Takakura, M Maeda, et al.
Lung Cancer (Amsterdam, Netherlands)|July 1, 1997
Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patientsN Takigawa, Y Segawa, Y Maeda, et al.
Endocrinologia Japonica|October 1, 1979
A case of the syndrome of inappropriate secretion of TSHT Sato, K Saida, Y Suzuki, et al.
Acta Medica Okayama|August 1, 1992
Establishment and characterization of a cell line, KaMi, from human lung large cell carcinomaH Takata, T Yoshino, Y Hoshida, et al.
International Journal of Immunopharmacology|July 1, 1995
Effect of a novel anti-rheumatic drug, TA-383, on type II collagen-induced arthritisM Ueno, K Imaizumi, T Sugita, et al.
Internal Medicine (Tokyo, Japan)|October 1, 1996
Clinical usefulness of serum cytokeratin 19 fragment as a tumor marker for lung cancerY Maeda, Y Segawa, N Takigawa, et al.
Pageof 8